Journal of Biological Chemistry 2014-04-18

Curcumin alters the salt bridge-containing turn region in amyloid β(1-42) aggregates.

Venus Singh Mithu, Bidyut Sarkar, Debanjan Bhowmik, Anand Kant Das, Muralidharan Chandrakesan, Sudipta Maiti, Perunthiruthy K Madhu

Index: J. Biol. Chem. 289(16) , 11122-31, (2014)

Full Text: HTML

Abstract

Amyloid β (Aβ) fibrillar deposits in the brain are a hallmark of Alzheimer disease (AD). Curcumin, a common ingredient of Asian spices, is known to disrupt Aβ fibril formation and to reduce AD pathology in mouse models. Understanding the structural changes induced by curcumin can potentially lead to AD pharmaceutical agents with inherent bio-compatibility. Here, we use solid-state NMR spectroscopy to investigate the structural modifications of amyloid β(1-42) (Aβ42) aggregates induced by curcumin. We find that curcumin induces major structural changes in the Asp-23-Lys-28 salt bridge region and near the C terminus. Electron microscopy shows that the Aβ42 fibrils are disrupted by curcumin. Surprisingly, some of these alterations are similar to those reported for Zn(2+) ions, another agent known to disrupt the fibrils and alter Aβ42 toxicity. Our results suggest the existence of a structurally related family of quasi-fibrillar conformers of Aβ42, which is stabilized both by curcumin and by Zn(2+.)


Related Compounds

Related Articles:

Mucoadhesive films containing chitosan-coated nanoparticles: a new strategy for buccal curcumin release.

2014-11-01

[J. Pharm. Sci. 103(11) , 3764-71, (2014)]

Enhancing the anti-inflammatory activity of chalcones by tuning the Michael acceptor site.

2015-03-14

[Org. Biomol. Chem. 13(10) , 3040-7, (2015)]

An antifungal mechanism of curcumin lies in membrane-targeted action within Candida albicans.

2014-11-01

[IUBMB Life 66(11) , 780-5, (2015)]

Identification of the cellular mechanisms that modulate trafficking of frizzled family receptor 4 (FZD4) missense mutants associated with familial exudative vitreoretinopathy.

2014-06-01

[Invest. Ophthalmol. Vis. Sci. 55(6) , 3423-31, (2014)]

Improved plasma membrane expression of the trafficking defective P344R mutant of muscle, skeletal, receptor tyrosine kinase (MuSK) causing congenital myasthenic syndrome.

2015-03-01

[Int. J. Biochem. Cell Biol. 60 , 119-29, (2015)]

More Articles...